All In Biotech

Free tool

FAERS Monitor: Ciloxan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019992 or its brand name (Ciloxan, Ciprofloxacin Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

6,204

Serious

5,373

87% of reports

Hospitalization

2,322

Death reported

523

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • vomiting752
  • pneumonia707
  • dyspnoea698
  • off label use668
  • pain654
  • nausea641
  • drug hypersensitivity637
  • malaise592
  • diarrhoea587
  • drug ineffective543
  • fatigue533
  • wheezing522
  • headache511
  • asthma456
  • oedema441

Reports by year received

View as table
YearReports
200441
200567
200663
200766
200889
2009163
201080
2011119
2012298
201372
201481
2015108
2016132
2017141
2018275
2019501
2020417
2021477
2022603
2023612
2024676
2025679
2026441

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,955 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
wheezingSignal52230.127.714,568
oedemaSignal44127.825.411,297
asthmaSignal45613.712.65,377
drug hypersensitivitySignal63711.210.45,938
pneumoniaSignal7077.46.93,971
vomitingSignal7525.45.12,771
malaiseSignal5924.64.21,687
dyspnoeaSignal6984.23.91,733
painSignal6543.63.41,269
diarrhoeaSignal5873.12.9850
headacheSignal5112.82.5591
nauseaSignal6412.72.6738
off label useSignal6682.62.4677
fatigueSignal5332.32.1415
drug ineffective5431.41.365

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.